PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13)
- 23 May 2003
- journal article
- case report
- Published by Springer Nature in Leukemia
- Vol. 17 (6), 1121-1123
- https://doi.org/10.1038/sj.leu.2402923
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Reversion of B Cell Commitment upon Loss of Pax5 ExpressionScience, 2002
- Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)Blood, 2001
- Commitment to the B-lymphoid lineage depends on the transcription factor Pax5Nature, 1999
- Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experimentsThe EMBO Journal, 1998
- BCR/ABL-negative chronic myeloid leukemia withETV6/ABL fusionGenes, Chromosomes and Cancer, 1997
- Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid LeukemiaBlood, 1997
- Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.Proceedings of the National Academy of Sciences, 1996
- Genomic organization of TEL: the human ETS-variant gene 6.Genome Research, 1996
- tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyBlood, 1987